Drug-Eluting Stent

News - Drug-Eluting Stent

Biosensors Reports Continued Strong Sales and Record Profits in the Fourth Quarter of Fiscal Year 2012

2012-05-29 02:26:58

SINGAPORE, May 29, 2012 /PRNewswire-Asia/ -- Biosensors International Group, Ltd.

InspireMD Announces Enrollment Completion In Master Trial

2012-05-24 02:27:54

TEL AVIV, Israel, May 24, 2012 /PRNewswire/ -- InspireMD, Inc.

PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study

2012-05-17 22:21:30

NATICK, Mass., May 18, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces two-year results from the PLATINUM Small Vessel study, demonstrating excellent safety and effectiveness

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC(TM) Vascular Stent

2012-05-17 10:26:10

NATICK, Mass., May 17, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces U.S.

Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses

2012-05-17 02:25:54

PARIS, May 17, 2012 /PRNewswire/ -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus

More News (1014 articles) »